Letter to the Editor: In Response to Hematology...Literally and Seriously
Dr. Rosenblum responds to The Hematologist Editor-in-Chief's commentary in the Year's Best issue.
A New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD
Dr. DeBaun evaluates a new agent for the prevention of vaso-occlusive pain episodes in sickle cell disease that holds promise for first FDA approval since hydroxyurea.
Opinion pieces written by leaders of the hematology community
Dr. Saultz and Dr. Devine discuss cord blood transplants in patients with MRD as an alternative donor source.
Dr. George and Dr. Gullapalli provide a thorough synopsis of the history of Theranos, a medical and technological innovations laboratory company founded by Elizabeth Holmes.
Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.
Dr. Cynthia Dunbar, Dr. Janis Abkowitz, Dr. Nancy Berliner, and Dr.
Susan Shurin discuss the concerted grassroots effort to nominate women
for ASH awards.
Congresswoman Louise Slaughter discusses the provisions of the bill she sponsored that protects the privacy of patients who undergo genetic testing.
Dr. Barry Coller discusses the concept of the physician as discoverer, highlighting how this model has been eroded by changes in medical education and training and suggesting measures that can be taken to restore it.
As both a part-time hematologist and mother, Dr. Lanie Francis shares advice on achieving success and satisfaction at home and at the office.
Dr. Meir Preis explains how new standards for resident duty hours may affect the organization of inpatient teaching services.
The fact is nearly all constituent communications are counted and responded to by Members of Congress and their staff. While it is true that individualized communications with some expression of personal sentiment or opinion are most likely to be influential, nearly all legislators do use constituent communications as a gauge of public opinion and integrate it into their decision-making.
Community-based private hematology practices are a valuable resource for the care and treatment of many patients with hematologic problems. Unfortunately, hematologists have recently seen a rapid increase in what had been a slow erosion of the incentives to enter and remain in such practices.
March-April 2017Volume 14, Issue 2
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology